BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ledda C, Costantino C, Motta G, Cunsolo R, Stracquadanio P, Liberti G, Maltezou HC, Rapisarda V. SARS-CoV-2 mRNA Vaccine Breakthrough Infections in Fully Vaccinated Healthcare Personnel: A Systematic Review. Trop Med Infect Dis 2022;7:9. [PMID: 35051125 DOI: 10.3390/tropicalmed7010009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Leggat PA, Frean J, Blumberg L. COVID-19: Current Status and Future Prospects. TropicalMed 2023;8:94. [DOI: 10.3390/tropicalmed8020094] [Reference Citation Analysis]
2 Sheng WH, Chang HC, Chang SY, Hsieh MJ, Chen YC, Wu YY, Pan SC, Wang JT, Chen YC. SARS-CoV-2 infection among healthcare workers whom already received booster vaccination during epidemic outbreak of omicron variant in Taiwan. J Formos Med Assoc 2022:S0929-6646(22)00442-9. [PMID: 36564300 DOI: 10.1016/j.jfma.2022.12.003] [Reference Citation Analysis]
3 Yang SL, Mat Ripen A, Leong CT, Lee JV, Yen CH, Chand AK, Koh K, Abdul Rahim NAB, Gokilavanan V, Mohamed NNEB, Sevalingam RKA, Sulaiman N, Ab Razak AKB, Mohd Nor NHB, Pong MK, Tai KY, Toh V, Woon YL, Peariasamy KM. COVID-19 breakthrough infections and humoral immune response among BNT162b2 vaccinated healthcare workers in Malaysia. Emerg Microbes Infect 2022;11:1262-71. [PMID: 35412409 DOI: 10.1080/22221751.2022.2065936] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
4 Helmy SA, El-Morsi RM, Helmy SAM, El-Masry SM. Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations. J Drug Deliv Sci Technol 2022;76:103762. [PMID: 36097606 DOI: 10.1016/j.jddst.2022.103762] [Reference Citation Analysis]
5 Psaridi L, Maltezou HC, Simonidou S, Lialliou I, Athanasopoulou D, Haila Z, Kyrimi A, Giannopoulou I, Giannousa S, Pseimada M, Christofilea O, Dounias G, Lanitis S, Kremasmenou E. Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection. Vaccine 2022:S0264-410X(22)01008-8. [PMID: 36008235 DOI: 10.1016/j.vaccine.2022.08.031] [Reference Citation Analysis]
6 Rivelli A, Fitzpatrick V, Copeland K, Richards J. Factors Associated With COVID-19 Breakthrough Infections in Large Midwestern Healthcare System: Implications for Vulnerable Healthcare Personnel. J Occup Environ Med 2022;64:635-41. [PMID: 35673248 DOI: 10.1097/JOM.0000000000002576] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Al Kalamouni H, Abou Hassan FF, Bou Hamdan M, Page AJ, Lott M, Ghosn N, Rady A, Mahfouz R, Araj GF, Dbaibo G, Zaraket H, Melhem NM, Matar GM. Genomic Surveillance of SARS CoV2 in COVID-19 vaccinated healthcare workers in Lebanon.. [DOI: 10.1101/2022.06.06.494965] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Golec M, Fronczek M, Zembala-john J, Chrapiec M, Konka A, Wystyrk K, Botor H, Brzoza Z, Kasperczyk S, Bułdak RJ. Early and Longitudinal Humoral Response to the SARS-CoV-2 mRNA BNT162b2 Vaccine in Healthcare Workers: Significance of BMI, Adipose Tissue and Muscle Mass on Long-Lasting Post-Vaccinal Immunity. Viruses 2022;14:868. [DOI: 10.3390/v14050868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]